MORPHOSYS AGMORPHOSYS AGMORPHOSYS AG

MORPHOSYS AG

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.55 B‬EUR
−12.69EUR
‪−189.73 M‬EUR
‪238.28 M‬EUR
‪18.44 M‬
Beta (1Y)
−0.11
Employees (FY)
564
Change (1Y)
−83 −12.83%
Revenue / Employee (1Y)
‪466.31 K‬EUR
Net income / Employee (1Y)
‪−371.31 K‬EUR

About MORPHOSYS AG


CEO
Arkadius Pichota
Headquarters
Planegg
Founded
1992
ISIN
DE0006632003
FIGI
BBG000C68XG4
MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MOR is 67.85 EUR — it has decreased by −0.07% in the past 24 hours. Watch MORPHOSYS AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MORPHOSYS AG stocks are traded under the ticker MOR.
MOR reached its all-time high on Jan 13, 2020 with the price of 145.00 EUR, and its all-time low was 1.57 EUR and was reached on Dec 20, 2002. View more price dynamics on MOR chart.
See other stocks reaching their highest and lowest prices.
MOR stock is 0.29% volatile and has beta coefficient of −0.11. Track MORPHOSYS AG stock price on the chart and check out the list of the most volatile stocks — is MORPHOSYS AG there?
Today MORPHOSYS AG has the market capitalization of ‪2.55 B‬, it has increased by 0.15% over the last week.
Yes, you can track MORPHOSYS AG financials in yearly and quarterly reports right on TradingView.
MORPHOSYS AG is going to release the next earnings report on Nov 18, 2024. Keep track of upcoming events with our Earnings Calendar.
MOR net income for the last quarter is ‪−79.19 M‬ EUR, while the quarter before that showed ‪−314.96 M‬ EUR of net income which accounts for 74.86% change. Track more MORPHOSYS AG financial stats to get the full picture.
No, MOR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2024, the company has 564.00 employees. See our rating of the largest employees — is MORPHOSYS AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MORPHOSYS AG EBITDA is ‪−433.78 M‬ EUR, and current EBITDA margin is −95.29%. See more stats in MORPHOSYS AG financial statements.
Like other stocks, MOR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MORPHOSYS AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MORPHOSYS AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MORPHOSYS AG stock shows the buy signal. See more of MORPHOSYS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.